ArticleAllergy, asthma & immunology research2026
Lifetime Atopic Dermatitis is Associated With Risk of Autoimmune Thyroid Disease: Evidence From a Nationwide Study.
Article in Allergy, asthma & immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of dermatology targeted immunotherapies on autoimmune thyroid diseases: cytokine-network crosstalk and thyroid safety.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between atopic dermatitis (AD) and autoimmune thyroid disease (AITD) has received increasing attention. We investigated the association between AD and the risk of AITD in the Korean adult population. The medical data from 5,410 individuals aged ≥ 19 years from the Korea National Health and Nutrition Examination Survey 2013-2015 were categorized into 2 groups: (1) the thyroid dysfunction group (if they met the criteria of overt hyperthyroidism or overt hypothyroidism) and (2) the anti-thyroid peroxidase antibody (anti-TPO Ab)-positive group. Thyroid dysfunction and anti-TPO Ab positivity were each regarded as surrogate markers for the risk of AITD. The association between AD and the risk of AITD was investigated using multivariable logistic regression analysis to obtain the adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Age-stratified analyses were performed to assess the AD-conferred risks in each age group. Among 5,410 subjects (mean age: 44 years; 51% male), the prevalence of AD, thyroid dysfunction, and anti-TPO Ab positivity was 3.5%, 1.0%, and 6.4%, respectively. Individuals with AD had a higher tendency of having thyroid dysfunction (aOR,1.65; 95% CI, 0.44-6.23) and anti-TPO Ab positivity (aOR, 1.40; 95% CI, 0.73-2.70); however, none of the associations reached statistical significance in this analysis. Nevertheless, in the young adult group (aged 19-39 years), a statistically significant association between AD and thyroid dysfunction (aOR, 5.86; 95% CI, 1.51-22.67) and a marginally significant association between AD and anti-TPO Ab positivity (aOR, 2.05; 95% CI 0.91-4.65;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.